CeQur Simplicity SA
8 News & Press Releases found
CeQur Simplicity SA news
CeQur®, a medical device company committed to simplifying the lives of people with diabetes by revolutionizing insulin-delivery solutions, today announced the appointments of Rick Doubleday and Meret Gaugler, Ph.D., to its Board of Directors.
Jun. 24, 2021
CeQur Raises $115 Million Series C5 Financing to Support Commercialization and Scale-Up of Automated Manufacturing for CeQur Simplicity Wearable Insulin-Delivery Device. CeQur, a medical device company committed to simplifying the lives of people with diabetes by revolutionizing insulin-delivery solutions, today announced the close of an oversubscribed $115 million equity financing. The company will use the funds to advance commercial plans for CeQur Simplicity™, including market deve
Apr. 12, 2021
Progression of Type 2 Diabetes Treatment
- Due to natural progression of type 2 diabetes, maintenance of glycemic targets requires a stepwise approach to treatment in order to achieve and maintain glycemic control and avoid complications1`2
- Comprehensive lifestyle modifications combined with metformin
- Addition of up to 3 oral medications or GLP-1 RA injection
- Addition of basal (long-acting) insulin
- Addition of mealtim
Jun. 15, 2020
Click here to open an external link.
ATTENTION:
You will be leaving CeQur’s website. CeQur does not control the content of the website you are visiting.
Jun. 5, 2019
CeQur announced that the company has appointed Bradley Paddock as chief executive officer, effective today. Paddock brings a track record of commercial medtech successes, notably leading sales up to $600 million during his eight-year tenure at Kyphon, Inc. Paddock also managed successful commercial operations for multiple industry-leading companies, including Stryker, Bausch + Lomb, Inc., and Medtronic, Inc.
Jun. 4, 2019